🔗 Share this article

This year's prestigious award in Physiology or Medicine has been awarded for revolutionary findings that clarify how the immune system attacks dangerous infections while sparing the body's own cells.

Three esteemed researchers—Japan's Prof. Sakaguchi and US scientists Mary Brunkow and Fred Ramsdell—received this accolade.

Their research identified unique "sentinels" within the defense system that remove malfunctioning immune cells that could harming the organism.

The findings are now paving the way for new treatments for immune disorders and malignancies.

These winners will share a monetary award worth 11 million Swedish kronor.

Decisive Discoveries

"The research has been essential for understanding how the body's defenses functions and the reason we don't all develop serious self-attack conditions," stated the chair of the award panel.

The trio's research explain a core question: How does the defense system protect us from countless infections while keeping our healthy cells intact?

The immune system employs white blood cells that scan for indicators of infection, including pathogens and germs it has not met before.

These cells utilize detectors—called receptors—that are produced randomly in a vast number of combinations.

This provides the immune system the ability to fight a wide array of threats, but the unpredictability of the mechanism inevitably produces white blood cells that may attack the body.

Security Guards of the Body

Researchers earlier understood that a portion of these harmful defense cells were destroyed in the immune organ—the site where white blood cells develop.

The latest award recognizes the discovery of regulatory T-cells—described as the immune system's "peacekeepers"—which patrol the body to disarm any defenders that assault the healthy cells.

We know that this process fails in autoimmune diseases such as type-1 diabetes, MS, and RA.

A prize committee added, "These findings have established a novel area of investigation and accelerated the development of new treatments, for example for cancer and immune disorders."

Regarding malignancies, regulatory T-cells block the body from fighting the tumor, so studies are aimed at lowering their numbers.

For self-attack disorders, experiments are exploring increasing regulatory T-cells so the organism is not being harmed. A comparable method could also be effective in reducing the risks of organ transplant rejection.

Innovative Experiments

Prof Shimon Sakaguchi, from Osaka University, performed tests on mice that had their thymus extracted, leading to self-attack conditions.

He demonstrated that injecting defense cells from healthy animals could stop the illness—implying there was a mechanism for preventing immune cells from attacking the body.

Dr. Brunkow, from the a research center in Seattle, and Fred Ramsdell, now at a biotech firm in San Francisco, were studying an inherited autoimmune disease in rodents and humans that led to the identification of a gene critical for the way regulatory T-cells operate.

"The pioneering work has revealed how the immune system is controlled by regulatory T cells, preventing it from mistakenly targeting the healthy cells," said a leading physiology expert.

"This work is a striking example of how basic biological research can have far-reaching implications for human health."